Prognosis in congestive heart failure
TS Rector, Ph. D, JN Cohn, MD - Annual review of medicine, 1994 - annualreviews.org
▪ Abstract Prognostic variables such as the ejection fraction and peak oxygen consumption
can be used to place patients with heart failure in risk strata. Some vasodilators have been
shown to improve survival at all stages of heart failure with the probability of benefit
increasing as the prognosis worsens. Quantitative estimates of survival among groups
defined by prognostic variables and treatments should be used to make more informed
benefit-to-risk assessments.
can be used to place patients with heart failure in risk strata. Some vasodilators have been
shown to improve survival at all stages of heart failure with the probability of benefit
increasing as the prognosis worsens. Quantitative estimates of survival among groups
defined by prognostic variables and treatments should be used to make more informed
benefit-to-risk assessments.
Prognosis in congestive heart failure
MJ Domanski, R Garg, S Yusuf - Congestive heart failure …, 1994 - Springer
Congestive heart failure (CHF) is a common affliction that is increasing in both incidence
and prevalence. In this chapter the prognosis of CHF is examined. The epidemiology will be
discussed first. Etiology is then considered with special reference to changes that have
occurred. Modes of death and predictors of outcome also are considered. This is followed by
an examination of the effect of treatment on prognosis.
and prevalence. In this chapter the prognosis of CHF is examined. The epidemiology will be
discussed first. Etiology is then considered with special reference to changes that have
occurred. Modes of death and predictors of outcome also are considered. This is followed by
an examination of the effect of treatment on prognosis.